Bioneutral Group, Inc. (BONU.OB), begins Independent EPA Testing
Welcome to the BioNeutral Group, Inc. web site
52 wk Range: $0.20-$1.56
Shares: 62.44M
Given the trading pattern of this stock, after the
reverse merger in Feb, I believe the stock will go up after the volume stabilizes.
It will trade around $2.50-$4.00 by the end of the year. It is a great buy at the lower end of the range. Also, it currently provides great opportunity for intraday and short term trading.
The Company has recently engaged Washington DC based, Dr. Matthew W. Brooks, Ph.D., Director of Ag-Chem Consulting LLC to oversee the independent EPA testing. Dr. Brooks' academic accomplishments include a Ph.D. in Chemistry, M.S. degrees in Pesticide Toxicology and Chemistry and a B.S. in Microbiology. He has published numerous peer reviewed articles on residue chemistry and pesticide mode of action and recently completed a book chapter on regulatory requirements for the textbook "Encyclopedia of Agrichemicals".
See,
BioNeutral Group, Inc. Begins Independent EPA Testing on Hospital Grade Ygiene™
http://studio-5.financialcontent.com...BONU&Client=ir
Also check this out,
1) BioNeutral Group, Inc. Appoints Tom Voltaggio,
Former Deputy Director of EPA to its Scientific Advisory Board
http://studio-5.financialcontent.com...BONU&Client=ir
2) BioNeutral Group, Inc. Announces Dr. Dorothy Canter,
Former EPA's Chief Scientist for Bioterrorism Issues, as Lead Homeland Security Consultant
http://studio-5.financialcontent.com...BONU&Client=ir